This compound is a pharmaceutical intermediate featuring an amide-linked glycine residue and a benzyl side chain. It is characterized by a sulfonate ester group and an aromatic ring, with a molecular weight of approximately 315 Da and moderate polarity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(R)-Ethyl 2-(2-benzyl-3-((methylsulfonyl)oxy)propanamido)acetate
pharmaceutical intermediate
N-[(2S)-2-[[(Methylsulfonyl)oxy]methyl]-1-oxo-3-phenylpropyl]-glycine ethyl ester
pharmaceutical intermediate
Methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl)oxy)-3-(trimethylsilyl)allyl)octahydropyrano[3,2-b]pyran-2-yl)acetate
pharmaceutical intermediate
Magnesium bromide 4-methoxy-3,5-dimethylbenzen-1-ide (1/1/1)
pharmaceutical intermediate
Agomelatine Dimer Urea
pharmaceutical intermediate
O-desmethyl tramadol hydrochloride
pharmaceutical intermediate
2-[[(2S)-2-benzyl-3-methylsulfonyloxypropanoyl]amino]acetic acid
FREXHGIWGSQYED-NSHDSACASA-N
CS(=O)(=O)OC[C@H](CC1=CC=CC=C1)C(=O)NCC(=O)O
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.